259 related articles for article (PubMed ID: 26301456)
1. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer.
Watkins JL; Thaker PH; Nick AM; Ramondetta LM; Kumar S; Urbauer DL; Matsuo K; Squires KC; Coleman RL; Lutgendorf SK; Ramirez PT; Sood AK
Cancer; 2015 Oct; 121(19):3444-51. PubMed ID: 26301456
[TBL] [Abstract][Full Text] [Related]
2. Impact of beta blockers on epithelial ovarian cancer survival.
Diaz ES; Karlan BY; Li AJ
Gynecol Oncol; 2012 Nov; 127(2):375-8. PubMed ID: 22819786
[TBL] [Abstract][Full Text] [Related]
3. Intake of selective beta blockers has no impact on survival in patients with epithelial ovarian cancer.
Heitz F; Hengsbach A; Harter P; Traut A; Ataseven B; Schneider S; Prader S; Kurzeder C; Sporkmann M; du Bois A
Gynecol Oncol; 2017 Jan; 144(1):181-186. PubMed ID: 27863705
[TBL] [Abstract][Full Text] [Related]
4. Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer.
Gonzalez R; Gockley AA; Melamed A; Sugrue R; Clark RM; Del Carmen MG; Growdon W; Berkowitz RS; Horowitz NS; Worley MJ
Gynecol Oncol; 2020 Jun; 157(3):700-705. PubMed ID: 32222327
[TBL] [Abstract][Full Text] [Related]
5. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
[TBL] [Abstract][Full Text] [Related]
6. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific associations between beta blocker use and prognosis after colorectal cancer.
Jansen L; Hoffmeister M; Arndt V; Chang-Claude J; Brenner H
Cancer; 2014 Apr; 120(8):1178-86. PubMed ID: 24415516
[TBL] [Abstract][Full Text] [Related]
8. Perioperative beta-blocker use and survival in lung cancer patients.
Cata JP; Villarreal J; Keerty D; Thakar DR; Liu DD; Sood AK; Gottumukkala V
J Clin Anesth; 2014 Mar; 26(2):106-17. PubMed ID: 24480297
[TBL] [Abstract][Full Text] [Related]
9. Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study.
Johannesdottir SA; Schmidt M; Phillips G; Glaser R; Yang EV; Blumenfeld M; Lemeshow S
BMC Cancer; 2013 Feb; 13():85. PubMed ID: 23433478
[TBL] [Abstract][Full Text] [Related]
10. beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures.
Reid IR; Gamble GD; Grey AB; Black DM; Ensrud KE; Browner WS; Bauer DC
J Bone Miner Res; 2005 Apr; 20(4):613-8. PubMed ID: 15765180
[TBL] [Abstract][Full Text] [Related]
11. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
[TBL] [Abstract][Full Text] [Related]
12. Impact of beta blockers on survival outcomes in ovarian cancer: a nationwide population-based cohort study.
Baek MH; Kim DY; Kim SO; Kim YJ; Park YH
J Gynecol Oncol; 2018 Nov; 29(6):e82. PubMed ID: 30207092
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of β-blocker use in pulmonary arterial hypertension: a propensity-matched analysis.
Bandyopadhyay D; Bajaj NS; Zein J; Minai OA; Dweik RA
Eur Respir J; 2015 Sep; 46(3):750-60. PubMed ID: 26022959
[TBL] [Abstract][Full Text] [Related]
14. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
15. The Beneficial Effect of Beta-Blockers in Patients With Cirrhosis, Portal Hypertension and Ascites.
Aday AW; Mayo MJ; Elliott A; Rockey DC
Am J Med Sci; 2016 Feb; 351(2):169-76. PubMed ID: 26897272
[TBL] [Abstract][Full Text] [Related]
16. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies.
Yap A; Lopez-Olivo MA; Dubowitz J; Pratt G; Hiller J; Gottumukkala V; Sloan E; Riedel B; Schier R
Br J Anaesth; 2018 Jul; 121(1):45-57. PubMed ID: 29935594
[TBL] [Abstract][Full Text] [Related]
17. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
Hansen O; Johansson BW
J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
[TBL] [Abstract][Full Text] [Related]
18. Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer.
Dizon DS; Weitzen S; Rojan A; Schwartz J; Miller J; Disilvestro P; Gordinier ME; Moore R; Tejada-Berges T; Pires L; Legare R; Granai CO
Gynecol Oncol; 2006 Feb; 100(2):417-21. PubMed ID: 16336992
[TBL] [Abstract][Full Text] [Related]
19. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Brodie B; Turco M; Rutherford BD; Aymong E; Lansky AJ; Stone GW
J Am Coll Cardiol; 2004 May; 43(10):1780-7. PubMed ID: 15145099
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada.
Kitchlu A; Clemens K; Gomes T; Hackam DG; Juurlink DN; Mamdani M; Manno M; Oliver MJ; Quinn RR; Suri RS; Wald R; Yan AT; Garg AX
Nephrol Dial Transplant; 2012 Apr; 27(4):1591-8. PubMed ID: 21873621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
